CRNX - Crinetics Pharmaceuticals, Inc.

QQQ $ 463.32 $ -0.16 (-0.03 %)

DIA $ 389.27 $ 0.80 (0.21 %)

SPY $ 534.63 $ -0.01 (0 %)

TLT $ 93.23 $ -0.14 (-0.15 %)

GLD $ 219.44 $ 1.61 (0.74 %)

Previous Close

$ 45.84

Open

$ 47.15

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 45.76 - $ 47.39

52 Week Range

$ 15.76 - $ 53.70

Volume

665,526

Average Volume

Market Cap

2.47B

Beta (5Y Monthly)

$ 0.88

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	02-28-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-09-2023	03-31-2023	10-Q
6	02-28-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-12-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-30-2022	12-31-2021	10-K
11	11-05-2021	09-30-2021	10-Q
12	08-10-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	03-30-2021	12-31-2020	10-K
15	11-06-2020	09-30-2020	10-Q
16	08-07-2020	06-30-2020	10-Q
17	05-08-2020	03-31-2020	10-Q
18	03-09-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-13-2019	06-30-2019	10-Q
21	05-13-2019	03-31-2019	10-Q
22	03-13-2019	12-31-2018	10-K
23	11-13-2018	09-30-2018	10-Q
24	08-30-2018	06-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

nvidia-to-rally-around-11-here-are-10-top-analyst-forecasts-for-tuesday

Nvidia To Rally Around 11%? Here Are 10 To...
06/04/2024 12:20:36

JMP Securities Reiterates Market Outperfor...
06/04/2024 12:19:30

JMP Securities analyst Jonathan Wolleben reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and mai...

Oppenheimer Maintains Outperform on Crinet...
06/04/2024 12:08:22

Oppenheimer analyst Leland Gershell maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and raises the price...

17 Analysts Have This To Say About Crineti...
06/04/2024 12:01:33

HC Wainwright & Co. Reiterates Buy on Crin...
06/04/2024 11:26:54

HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and maintains $60...

Crinetics To Present New Data Results Of T...
06/03/2024 16:02:02

First Scientific Presentation of PATHFNDR-2 Acromegaly Safety and Efficacy Data Following Positive Topline Announcement, Showin...

Baird Maintains Outperform on Crinetics Ph...
05/23/2024 16:37:36

Baird analyst Brian Skorney maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and raises the price target ...

Morgan Stanley Maintains Overweight on Cri...
05/23/2024 15:23:26

Morgan Stanley analyst Jeffrey Hung maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Overweight and raises the price...

HC Wainwright & Co. Reiterates Buy on Crin...
05/23/2024 11:15:39

HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and maintains $60...

analog-devices-posts-strong-earnings-joins-tjx-williams-sonoma-and-other-big-stocks-moving-higher-on-wednesday

Analog Devices Posts Strong Earnings, Join...
05/22/2024 14:22:53

Market-Moving News for May 22nd
05/22/2024 12:34:04

CRNX: 11% | Crinetics Pharmaceuticals shares are trading higher after the company announced the early release of ENDO 2024 late...

Crinetics Pharmaceuticals Announces ENDO 2...
05/22/2024 12:02:50

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) a clinical stage pharmaceutical company focused on the discovery, development and...

18 Analysts Have This To Say About Crineti...
05/14/2024 16:00:29

Cantor Fitzgerald Reiterates Overweight on...
05/14/2024 12:45:28

Cantor Fitzgerald analyst Josh Schimmer reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Overweight and maintains $...

HC Wainwright & Co. Reiterates Buy on Crin...
05/10/2024 19:40:30

HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and maintains $60...

JMP Securities Reiterates Market Outperfor...
05/10/2024 16:45:04

JMP Securities analyst Jonathan Wolleben reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and mai...

Crinetics Pharmaceuticals Q1 2024 GAAP EPS...
05/09/2024 20:40:40

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.93) per share which missed the analyst consensus estim...

Crinetics Pharmaceuticals To Present Advan...
05/08/2024 21:44:45

Initial Data from Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia to be Presented, Along with Initial Findings fr...

Piper Sandler Maintains Overweight on Crin...
05/07/2024 11:08:29

Piper Sandler analyst Yasmeen Rahimi maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Overweight and raises the pric...

Live On CNBC, StemPoint Capital CIO Michel...
04/03/2024 16:40:31